Filing Details
- Accession Number:
- 0001437749-25-023545
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-25 18:43:29
- Reporting Period:
- 2025-07-23
- Filing Date:
- 2025-07-25
- Accepted Time:
- 2025-07-25 18:43:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1504678 | Loop Industries Inc. | LOOP | Chemicals & Allied Products (2800) | 272094706 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649149 | Daniel Solomita | 480 Fernand Poitras Terrebonne A8 J6Y1Y4 | Chief Executive Officer | Yes | Yes | Yes | No |
Transaction Summary
Purchased: | 906,794 shares | Avg. Price: $1.01 | Total Value: $915,499.22 |
Number of Shares After Transactions: | 1,415,516 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-07-23 | 906,794 | $1.01 | 1,415,516 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 18,600,000 | Indirect | See Footnote |
Common Stock | 3,400,000 | Direct |
Footnotes
- Shares held through 10036552 Canada Inc., a Canadian corporation that is wholly-owned by Daniel Solomita.
- Shares underlying restricted stock units approved by the Board and were issued following the 2019 annual general meeting of shareholders of the Issuer, following the shareholders' approval of an increase in the number of shares of common stock reserved under the equity incentive plan. On October 15 of 2019, 2020, and 2021, each, 200,000 restricted stock units were settled. Settled shares are included in the first row of Column 5 above.